SCHEMBL24919192

SCHEMBL24919192

c1cc(-c2ccc3ccccc3c2)cc(N(c2ccc(-c3ccc4c(ccc5ccccc54)c3)cc2)c2cccc3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.40
HSD17B2 P37059 4/20 0.40
ESR1 P03372 5/20 0.38
ESR2 Q92731 5/20 0.38
CYP1B1 Q16678 3/20 0.36
ALDH1A1 P00352 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 3/20 0.35
CYP1A1 P04798 2/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
SIGMAR1 Q99720 2/20 0.34
HPRT1 P00492 2/20 0.34
ERBB2 P04626 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13829294 0.95 HSD17B1 (0.38) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL23225098 0.94 HSD17B1 (0.41) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL23224715 0.94 HSD17B1 (0.41) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL24919743 0.93 HSD17B1 (0.39) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL24816567 0.93 HSD17B1 (0.39) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL14070245 0.93 ALDH1A1 (0.37) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL24919724 0.93 HSD17B1 (0.41) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL13580179 0.93 HSD17B1 (0.39) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL25088129 0.92 CA1 (0.37) HSD17B1HSD17B2ESR1ESR2CYP1B1
SCHEMBL23448775 0.92 HSD17B1 (0.36) HSD17B1HSD17B2ESR1ESR2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 HSD17B1 2196/4885HSD17B2 2389/4885ESR1 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.